Heron Therapeutics, Inc. · NASDAQ:HRTX
The Vanguard Group reported a 5.35% stake in Heron Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.35% stake in Heron Therapeutics, Inc., 9,820,384 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.35%
- Shares
- 9,820,384
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.35% | 9,820,384 |
Source
Related
- Heron Therapeutics, Inc.
- The Vanguard Group
- Heron Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Oct 30, 2025
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026